Your browser doesn't support javascript.
loading
Heart/breathing rate ratio (HBR) as a predictor of mortality in critically ill patients.
Zhang, Tong Yan; Du, Ya Jun; Hou, Ya Zhu; Du, Qian; Dou, Hai Rong; Gao, Xiu Mei.
Affiliation
  • Zhang TY; Infectious Diseases Department, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Du YJ; TEDA International Cardiovascular Hospital, Tianjin, China.
  • Hou YZ; Department of Cardiology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
  • Du Q; Department of Pharmacy, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Dou HR; Infectious Diseases Department, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Gao XM; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Heliyon ; 10(10): e31187, 2024 May 30.
Article de En | MEDLINE | ID: mdl-38803872
ABSTRACT

Objectives:

The early prediction of death is a challenge for medical staff. We evaluated the ability of the heart/breathing rate ratio (HBR) to predict mortality.

Methods:

This was a single-center retrospective observational study of adult patients who had fever with or without respiratory symptoms, who survived at least 2 h after visiting the hospital, and whose lactate levels and vital signs were tested. We evaluated the distribution of mortality at different HBR levels and compared HBR with lactate.

Results:

A total of 18,872 fever clinic visits were screened, and 183 patients whose lactate levels were tested were recruited. Patients who had HBR values lower than 4·5 or higher than 5·5 had greater mortality than patients who had HBR values between 4·5 and 5·5 (21·3 % vs. 3·4 %, p = 0·003; 28·9 % vs. 3·4 %, p < 0·001, respectively). In patients whose HBR was <5, the AUROC for HBR for mortality was 0·762 (95 % CI 0.643-0·880), and that for lactate was 0·701 (95 % CI 0·564-0·837). In patients whose HBR was ≥5, the AUROC for HBR for mortality was 0·721 (95 % CI 0·584-0·857), and that for lactate was 0·742 (95 % CI 0·607-0·848).

Conclusions:

HBR is helpful for stratifying mortality risk among critically ill patients in acute care clinics for infectious diseases.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Heliyon Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Heliyon Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni